Intestinal Research

Inflammatory bowel diseases
Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models: Emiko Mizoguchi, Daren Low, Yui Ezaki, Toshiyuki Okada; Intest Res. 2020;18(2):151-167. Published online April 20, 2020; DOI: https://doi.org/10.5217/ir.2019.09154
Cited By 57; Full text PubReader ePub Crossref - TDM PDF

Novel biomarkers for the diagnosis and prognosis of colorectal cancer: Hyung-Hoon Oh, Young-Eun Joo; Intest Res. 2020;18(2):168-183. Published online November 30, 2019; DOI: https://doi.org/10.5217/ir.2019.00080
Cited By 40; Full text PubReader ePub Crossref - TDM PDF

Inflammatory bowel diseases
Fibrostenotic strictures in Crohn’s disease: Jun Hwan Yoo, Stefan Holubar, Florian Rieder; Intest Res. 2020;18(4):379-401. Published online April 10, 2020; DOI: https://doi.org/10.5217/ir.2019.09148
Cited By 24; Full text PubReader ePub Crossref - TDM PDF

Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases: Jung Min Kim, Jae Hee Cheon; Intest Res. 2020;18(3):249-264. Published online April 18, 2020; DOI: https://doi.org/10.5217/ir.2019.00128
Cited By 24; Full text PubReader ePub Crossref - TDM PDF

Prevalence and patient awareness of inflammatory bowel disease in Kazakhstan: a cross-sectional study: Jamilya Kaibullayeva, Aliya Ualiyeva, Ainash Oshibayeva, Anar Dushpanova, John K. Marshall; Intest Res. 2020;18(4):430-437. Published online September 29, 2020; DOI: https://doi.org/10.5217/ir.2019.00099
Cited By 23; Full text PubReader ePub Crossref - TDM PDF

The prevalence of sarcopenia and its effect on prognosis in patients with Crohn’s disease: Chan Hyung Lee, Hyuk Yoon, Dong Jun Oh, Jae Min Lee, Yoon Jin Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Joo Sung Kim; Intest Res. 2020;18(1):79-84. Published online January 30, 2020; DOI: https://doi.org/10.5217/ir.2019.00107
Cited By 21; Full text PubReader ePub Crossref - TDM PDF

Intestinal tuberculosis or Crohn’s disease: a review of the diagnostic models designed to differentiate between these two gastrointestinal diseases: Julajak Limsrivilai, Nonthalee Pausawasdi; Intest Res. 2021;19(1):21-32. Published online April 22, 2020; DOI: https://doi.org/10.5217/ir.2019.09142
Cited By 20; Full text PubReader ePub Crossref - TDM PDF

Use of thiopurines in inflammatory bowel disease: an update: Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, Amit Kumar Dutta, Abhinav Anand, Charles N. Bernstein, Devendra Desai, C. Ganesh Pai, Govind Makharia, Harsh Vardhan Tevethia, Joyce WY Mak, Kirandeep Kaur, Kiran Peddi, Mukesh Kumar Ranjan, Perttu Arkkila, Rakesh Kochhar, Rupa Banerjee, Saroj Kant Sinha, Siew Chien Ng, Stephen Hanauer, Suhang Verma, Usha Dutta, Vandana Midha, Varun Mehta, Vineet Ahuja, Ajit Sood; Intest Res. 2022;20(1):11-30. Published online April 15, 2021; DOI: https://doi.org/10.5217/ir.2020.00155
Cited By 18; Full text PubReader ePub Crossref - TDM PDF

Inflammatory bowel diseases
NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease: Katsuyoshi Matsuoka; Intest Res. 2020;18(3):275-281. Published online June 3, 2020; DOI: https://doi.org/10.5217/ir.2020.00002
Cited By 17; Full text PubReader ePub Crossref - TDM PDF

Clinical management for small bowel of Crohn’s disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion: Kenji Watanabe; Intest Res. 2020;18(4):347-354. Published online October 26, 2020; DOI: https://doi.org/10.5217/ir.2020.00032
Cited By 16; Full text PubReader ePub Crossref - TDM PDF

Miscellaneous
Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation: Young Sook Park, Soo Hyung Kim, Jong Won Park, Younglim Kho, Pu Rum Seok, Jae-Ho Shin, Yoon Ji Choi, Jin-Hyun Jun, Hee Chan Jung, Eun Kyung Kim; Intest Res. 2020;18(3):325-336. Published online June 23, 2020; DOI: https://doi.org/10.5217/ir.2019.00093
Cited By 16; Full text PubReader ePub Crossref - TDM PDF

Inflammatory Bowel Diseases
Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis: Shin Ju Oh, Ga Young Shin, Hosim Soh, Jae Gon Lee, Jong Pil Im, Chang Soo Eun, Kang-Moon Lee, Dong Il Park, Dong Soo Han, Hyo Jong Kim, Chang Kyun Lee; Intest Res. 2021;19(3):323-331. Published online August 18, 2020; DOI: https://doi.org/10.5217/ir.2020.00039
Cited By 14; Full text PubReader ePub Crossref - TDM PDF

Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study: Choon Jin Ooi, Ida Normiha Hilmi, Hyo-Jong Kim, Umesh Jalihal, Deng-Chyang Wu, Dirk Demuth, Dirk Lindner, Shashi Adsul; Intest Res. 2021;19(1):71-82. Published online September 4, 2020; DOI: https://doi.org/10.5217/ir.2019.09159
Cited By 14; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Inflammatory bowel diseases
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases: Soo-Kyung Park, Chang Hwan Choi, Jaeyoung Chun, Heeyoung Lee, Eun Sun Kim, Jae Jun Park, Chan Hyuk Park, Bo-In Lee, Yunho Jung, Dong-Il Park, Do Young Kim, Hana Park, Yoon Tae Jeen, IBD Research Group of the Korean Association for the Study of Intestinal Diseases; Intest Res. 2020;18(1):18-33. Published online January 30, 2020; DOI: https://doi.org/10.5217/ir.2019.09155
Cited By 14; Full text PubReader ePub Crossref - TDM PDF

Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases: Sang Hyoung Park, Jae Cheol Park, Milan Lukas, Martin Kolar, Edward V. Loftus, Jr; Intest Res. 2020;18(1):34-44. Published online January 30, 2020; DOI: https://doi.org/10.5217/ir.2019.09147
Cited By 14; Full text PubReader ePub Crossref - TDM PDF

Most cited